Advertisement

Topics

NeuroPace, Inc. Company Profile

14:16 EDT 26th March 2019 | BioPortfolio

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive Neurostimulator (RNS™) system for treating medically refractory epilepsy.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Location

1375 Shorebird Way
Mountain View
California
94043
United States of America

Contact

Phone: 1.650.237.2700
Fax: 1.650.237.2701
Email: info@neuropace.com


News Articles [7 Associated News Articles listed on BioPortfolio]

NeuroPace’s RNS system improves quality of life in long-term treatment study

The long-term treatment study assessed 256 patients across 33 epilepsy centers with around 1,900 patient implant years of follow-up. The RNS system has helped in better seizure reduction The post Neu...

NeuroPace Announces New Category I CPT Code from AMA for Electrocorticography from an Implanted Brain Neurostimulator

Supports Value of Insights Provided by Brain Recordings from the NeuroPace RNS® System for Drug-Resistant Epilepsy NeuroPace, Inc., a Silicon Valley-based medical tech...

NeuroPace Announces Final Results from the Largest Prospective Clinical Study in the Field of Neuromodulation with 9-Year Follow-Up at the 2018 American Epilepsy Society Annual Meeting

More than One-Third of Drug-Resistant Epilepsy Patients Achieved ≥90% Seizure Reduction with the RNS System American Epilepsy Society Annual Meeting, Booth 519—NeuroPace, ...

Global Sacral Nerve Stimulators Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Vagal Nerve Stimulators Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Brain Implants Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Neuromodulation Devices Market Research Report 20122024 [Report Updated: 01011970] Prices from USD $2260

The global Neuromodulation Devices market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product ty...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Bony encapsulation of a NeuroPace subdural electrode.

Responsive neurostimulation: Review of clinical trials and insights into focal epilepsy.

The responsive neurostimulator (RNS ®, NeuroPace Inc.) has been available clinically since 2013 for the treatment of medically refractory partial epilepsy. Using intracranial electrodes and a cranial...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of an External Responsive Neurostimulator System on Epileptiform Activity

This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulat...

Companies [1 Associated Companies listed on BioPortfolio]

NeuroPace, Inc.

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the tre...

More Information about "NeuroPace, Inc." on BioPortfolio

We have published hundreds of NeuroPace, Inc. news stories on BioPortfolio along with dozens of NeuroPace, Inc. Clinical Trials and PubMed Articles about NeuroPace, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroPace, Inc. Companies in our database. You can also find out about relevant NeuroPace, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record